Opportunity Information: Apply for CDC RFA PS10 10149
Apply for CDC RFA PS10 10149
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Prevention of HIV Transmission through Strengthening Blood Safety in the Republic of Zimbabwe under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Mar 16, 2010 and posted on Mar 16, 2010.
- Applicants must submit their applications by May 17, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $9,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,800,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Centers for Disease Control and Prevention (CDC), through its Procurement and Grants Office, released a discretionary funding opportunity under PEPFAR titled "Prevention of HIV Transmission through Strengthening Blood Safety in the Republic of Zimbabwe." The program is set up as a cooperative agreement, which generally means CDC expects to have substantial involvement with the recipient during implementation rather than simply issuing funds with minimal engagement. The overall intent is to reduce HIV transmission risk associated with blood transfusions by strengthening Zimbabwe's blood safety systems within the country's national framework, rather than creating a parallel program.
The core program priorities center on two practical areas that directly affect the safety and reliability of the blood supply. First, the opportunity emphasizes strengthening blood donor recruitment and retention. This typically points to building and sustaining a stable base of voluntary, repeat donors, since repeat donors are often associated with lower infectious risk compared to first time or replacement donors. Improving recruitment and retention can include better donor outreach strategies, donor education, improved donor experience, and systems that make it easier to bring donors back regularly. Second, the announcement highlights reducing blood processing time by improving laboratory administration and diagnostic capability. In operational terms, that focus suggests investments in laboratory workflow, quality systems, management practices, and testing capacity so that donated blood can be screened and processed more efficiently without compromising quality. Faster processing can reduce shortages and wastage, and it can help ensure that facilities receive safe blood products in a timely manner.
Funding details indicate CDC expected to make one award, with approximately USD 1,800,000 available in fiscal year 2010 for that single award. The award ceiling is USD 1,800,000 and there is no stated minimum award amount (award floor listed as 0). While the fiscal year 2010 amount is called out, the total estimated funding across the broader project period is listed as USD 9,000,000, implying the initiative was planned as a multi year effort with continued funding subject to availability and satisfactory performance. The estimated performance period begins September 30, 2010 and ends September 30, 2013, reflecting a three year implementation window.
From an eligibility standpoint, the listing states "unrestricted," meaning it is open to any type of entity unless the full announcement includes additional clarifications or limitations in its eligibility section. There is no cost sharing or matching requirement, which reduces barriers for applicants that may not be able to contribute non federal funds. The opportunity is categorized under Health, and it is associated with CFDA number 93.067 (Global AIDS), aligning it with PEPFAR and broader U.S. government HIV/AIDS investments.
Key administrative dates show the announcement was posted March 16, 2010, with an application deadline of May 17, 2010, and an archive date of June 16, 2010. Applicants were directed to Grants.gov for the complete program description and application requirements. For technical difficulties accessing the full announcement, the CDC Procurement and Grants Office Technical Information and Management Section (TIMS) was listed as the point of contact via phone at 770-488-2700.
Frequently Asked Questions (FAQs)
What is the name of this CDC funding opportunity?
The opportunity is titled "Prevention of HIV Transmission through Strengthening Blood Safety in the Republic of Zimbabwe" and is released by the Centers for Disease Control and Prevention (CDC) under PEPFAR.
Which CDC office released the opportunity?
It was released through the CDC Procurement and Grants Office.
What type of award mechanism is being used?
This opportunity is a cooperative agreement.
What does it mean that this is a cooperative agreement?
A cooperative agreement generally indicates CDC expects substantial involvement with the recipient during implementation, rather than providing funds with minimal federal engagement.
What is the overall purpose of the program?
The intent is to reduce HIV transmission risk associated with blood transfusions by strengthening Zimbabwe's blood safety systems within the national framework, rather than creating a parallel program.
Where is the program focused geographically?
The program focuses on strengthening blood safety in the Republic of Zimbabwe.
What are the main program priorities?
The core priorities are (1) strengthening blood donor recruitment and retention, and (2) reducing blood processing time by improving laboratory administration and diagnostic capability.
What does "strengthening blood donor recruitment and retention" involve in this opportunity?
The announcement emphasizes building and sustaining a stable base of voluntary, repeat donors. Activities commonly associated with this priority (as described in the opportunity summary) include improving donor outreach strategies, donor education, the donor experience, and systems that make it easier for donors to return regularly.
Why does the opportunity emphasize voluntary, repeat donors?
The description notes that repeat donors are often associated with lower infectious risk compared to first-time or replacement donors.
What does "reducing blood processing time" mean in practical terms?
The opportunity points to improving laboratory administration and diagnostic capability, which suggests strengthening laboratory workflow, quality systems, management practices, and testing capacity so donated blood can be screened and processed more efficiently without compromising quality.
How can faster blood processing help the blood supply?
The summary indicates that faster processing can reduce shortages and wastage and help ensure facilities receive safe blood products in a timely manner.
How many awards did CDC expect to make?
CDC expected to make one award.
How much funding was available for the award in fiscal year 2010?
Approximately USD 1,800,000 was available in fiscal year 2010 for the single award.
What is the maximum (ceiling) award amount?
The award ceiling is USD 1,800,000.
Is there a minimum (floor) award amount?
No minimum award amount is stated (the award floor is listed as 0).
Is this a multi-year program?
Yes. While the fiscal year 2010 amount is specified, the total estimated funding across the broader project period is listed as USD 9,000,000, implying a multi-year effort with continued funding subject to availability and satisfactory performance.
What is the project/performance period for this opportunity?
The estimated performance period begins September 30, 2010 and ends September 30, 2013 (a three-year implementation window).
Is there a cost sharing or matching requirement?
No. The opportunity states there is no cost sharing or matching requirement.
Who is eligible to apply?
The listing states eligibility is "unrestricted," meaning it is open to any type of entity unless the full announcement includes additional eligibility details or limitations.
What is the program category for this opportunity?
The opportunity is categorized under Health.
What CFDA number is associated with this opportunity?
The opportunity is associated with CFDA number 93.067 (Global AIDS).
How is this opportunity connected to PEPFAR?
It is a PEPFAR discretionary funding opportunity and aligns with CFDA 93.067 (Global AIDS), indicating it sits within broader U.S. government HIV/AIDS investments.
When was the announcement posted?
The announcement was posted March 16, 2010.
What was the application deadline?
The application deadline was May 17, 2010.
When was the opportunity archived?
The archive date was June 16, 2010.
Where were applicants directed to find the full program description and application requirements?
Applicants were directed to Grants.gov for the complete program description and application requirements.
Who should applicants contact for technical difficulties accessing the full announcement?
For technical difficulties, the point of contact listed is the CDC Procurement and Grants Office Technical Information and Management Section (TIMS) at 770-488-2700.
Browse more opportunities from the same category: Health
Next opportunity: OJJDP FY 2010 Missing and Exploited Children National Training and Technical Assistance Program
Previous opportunity: OJJDP FY 2010 Missing and Exploited Children Program Support
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS10 10149
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS10 10149) also looked into and applied for these:
| Funding Opportunity |
|---|
| Technical Assistance to Strengthen Blood Safety of the Ministry of Health in the Central Asian Republics of Kazakhstan, Kyrgyz Republic, Tajikistan, Turkmenistan, and Uzbekistan Under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10104 Funding Number: CDC RFA PS10 10104 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| HIV/AIDS Program Implementation Support Through Local Universities in the Federal Democratic Republic of Ethiopia Under The Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10114 Funding Number: CDC RFA PS10 10114 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| AIDS Education and Training Center (AETC) National Center for Expansion of HIV Care in Minority Communities Building Capacity in Community Health Centers Apply for HRSA 10 121 Funding Number: HRSA 10 121 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| The Role of Cellular Organelles in Alcohol Induced Tissue Injury (R01) Apply for PA 10 085 Funding Number: PA 10 085 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| The Role of Cellular Organelles in Alcohol Induced Tissue Injury (R21) Apply for PA 10 086 Funding Number: PA 10 086 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Stress Pathways in Alcohol Induced Organ Injury and Protection (R21) Apply for PA 10 094 Funding Number: PA 10 094 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Stress Pathways in Alcohol Induced Organ Injury and Protection (R01) Apply for PA 10 093 Funding Number: PA 10 093 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Use Disorders Treatment, Services Research, and Recovery (R01) Apply for PA 10 100 Funding Number: PA 10 100 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Use Disorders Treatment, Services Research, and Recovery (R21) Apply for PA 10 102 Funding Number: PA 10 102 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Alcohol Use Disorders Treatment, Services Research, and Recovery (R03) Apply for PA 10 101 Funding Number: PA 10 101 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Secondary Analyses of Social and Behavioral Datasets in Aging (R03) Apply for PA 10 139 Funding Number: PA 10 139 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technical Assistance to Behavior Change Communication (BCC) on Comprehensive Peer Education Program and the National AIDS Resource Center (NARC) Programs under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10116 Funding Number: CDC RFA PS10 10116 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,000,000 |
| Ancillary Studies in Clinical Trials (R01) Apply for RFA HL 10 024 Funding Number: RFA HL 10 024 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Hepatitis C Treatment Expansion Initiative Evaluation and Technical Assistance Center Apply for HRSA 10 216 Funding Number: HRSA 10 216 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Division of Diabetes Translation Earmarks 2010 Apply for CDC RFA DP10 1004E Funding Number: CDC RFA DP10 1004E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Transforming Biomedicine at the Interface of the Life and Physical Sciences (R01) Apply for PAR 10 141 Funding Number: PAR 10 141 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Centers of Excellence for Research on CAM (CERC) for Pain (P01) Apply for RFA AT 10 002 Funding Number: RFA AT 10 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Methods for Prevention Packages Program (MP3 II) (R01) Apply for RFA AI 10 005 Funding Number: RFA AI 10 005 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| Exceptional, Unconventional Research Enabling Knowledge Acceleration (EUREKA) In the Epilepsies (R01) Apply for RFA NS 11 003 Funding Number: RFA NS 11 003 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| New Biomedical Frontiers at the Interface of the Life and Physical Sciences (R01) Apply for PAR 10 142 Funding Number: PAR 10 142 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS10 10149", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.